Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Safety|August 30, 2014
DPP-4 inhibitors: pharmacological differences and their clinical implicationsAntonio Ceriello, Liberata Sportiello, Concetta Rafaniello, et al.
Pharmacological Research|November 9, 2017
Strengths, weaknesses and future challenges of biosimilars' development. An opinion on how to improve the knowledge and use of biosimilars in clinical practiceCristina Scavone, Concetta Rafaniello, Liberato Berrino, et al.
International Immunopharmacology|April 21, 2020
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatmentGabriella di Mauro, Cristina Scavone, Concetta Rafaniello, et al.
Gels (Basel, Switzerland)|July 25, 2022
Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its LimitsMartine Tarsitano, Maria Chiara Cristiano, Massimo Fresta, et al.
Expert Opinion on Drug Safety|August 30, 2014
Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideationAnnalisa Capuano, Cristina Scavone, Concetta Rafaniello, et al.
International Journal of Cardiology|October 14, 2015
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapyLiberata Sportiello, Concetta Rafaniello, Cristina Scavone, et al.
Journal of Gambling Studies|January 24, 2019
Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting SystemCristina Scavone, Barbara Stelitano, Concetta Rafaniello, et al.
Drug Safety|February 14, 2016
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical CasesAnnamaria Mascolo, Concetta Rafaniello, Liberata Sportiello, et al.
Journal of Clinical Medicine|September 9, 2022
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction's Reporting? A Pharmacovigilance Study in Southern ItalyClaudia Rossi, Rosanna Ruggiero, Liberata Sportiello, et al.
Frontiers in Pharmacology|May 1, 2020
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting SystemCristina Scavone, Annamaria Mascolo, Rosanna Ruggiero, et al.
Pageof 10